Mesoblast Limited
MEOBF
$1.55
-$0.04-2.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.37M | -98.26M | -102.14M | -102.75M | -103.35M |
| Total Depreciation and Amortization | 8.63M | 7.51M | 6.40M | 5.35M | 4.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.58M | 47.70M | 48.83M | 51.86M | 54.90M |
| Change in Net Operating Assets | -20.48M | -11.76M | -3.04M | -715.50K | 1.61M |
| Cash from Operations | -59.64M | -54.80M | -49.95M | -46.25M | -42.54M |
| Capital Expenditure | -996.00K | -838.00K | -680.00K | -431.50K | -183.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.00K | 341.00K | 800.00K | 800.50K | 801.00K |
| Cash from Investing | -1.11M | -497.00K | 120.00K | 369.00K | 618.00K |
| Total Debt Issued | 71.35M | 35.68M | -- | -- | -- |
| Total Debt Repaid | -76.66M | -43.21M | -9.77M | -12.36M | -14.96M |
| Issuance of Common Stock | 170.59M | 168.49M | 166.38M | 96.71M | 27.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.81M | -12.05M | -9.28M | -8.49M | -7.70M |
| Cash from Financing | 150.47M | 148.90M | 147.34M | 75.86M | 4.39M |
| Foreign Exchange rate Adjustments | 2.23M | 1.66M | 1.09M | -450.50K | -1.99M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.95M | 95.27M | 98.59M | 29.53M | -39.53M |